Chromadex Corp’s recent filing unveils that its Director Jaksch Frank L Jr unloaded Company’s shares for reported $0.23 million on Dec 13 ’24. In the deal valued at $6.19 per share,37,161 shares were sold. As a result of this transaction, Jaksch Frank L Jr now holds 244,179 shares worth roughly $1.33 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Frank Jaksch Jr. bought 37,161 shares, generating $229,961 in total proceeds.
Before that, Pamir Ozan bought 2,907 shares. Chromadex Corp shares valued at $21,397 were divested by the Chief Financial Officer at a price of $7.36 per share. As a result of the transaction, Pamir Ozan now holds 2,907 shares, worth roughly $15814.080000000002.
Oppenheimer downgraded its Chromadex Corp [CDXC] rating to a Perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who decreased its forecast for the stock in mid August from “a Buy” to “a Neutral”. ROTH Capital began covering CDXC with “Buy” recommendation on March 08, 2022. Oppenheimer started covering the stock on October 16, 2019. It rated CDXC as “an Outperform”.
Price Performance Review of CDXC
On Tuesday, Chromadex Corp [NASDAQ:CDXC] saw its stock jump 2.64% to $5.44. Over the last five days, the stock has lost -7.17%. Chromadex Corp shares have risen nearly 289.51% since the year began. Nevertheless, the stocks have risen 284.14% over the past one year. While a 52-week high of $7.97 was reached on 11/29/24, a 52-week low of $1.36 was recorded on 01/23/24. SMA at 50 days reached $5.89, while 200 days put it at $3.90.
Levels Of Support And Resistance For CDXC Stock
The 24-hour chart illustrates a support level at 5.28, which if violated will result in even more drops to 5.12. On the upside, there is a resistance level at 5.53. A further resistance level may holdings at 5.62. The Relative Strength Index (RSI) on the 14-day chart is 38.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.91%. Stochastics %K at 7.17% indicates the stock is a buying.
How much short interest is there in Chromadex Corp?
A steep rise in short interest was recorded in Chromadex Corp stocks on 2024-11-29, dropping by -0.61 million shares to a total of 2.0 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 2.6 million shares. There was a decline of -30.39%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 14, 2019 when B. Riley FBR began covering the stock and recommended ‘”a Buy”‘ rating along with a $7 price target.
